|
|
| Return to Deals of Year 2012: Main index | |
| AIG | |
| Size | $6 billion sell-down of AIA (Hong Kong) |
| Joint global coordinators | Deutsche Bank, Goldman Sachs, Morgan Stanley and Citigroup |
| Deal write-up | |
| Sinopec | |
| Size | Acquisition of a 49% equity interest in Talisman’s UK subsidiary for $1.5 billion in cash |
| Advisers | HSBC (Sinopec), JP Morgan (Talisman) |
| Deal write-up | |
| Genting Singapore | |
| Size | S$1.8 billion perpetual subordinated capital securities |
| Joint global coordinators | HSBC, CIMB Bank, DBS, Deutsche Bank and JPMorgan |
| Deal write-up | |
| Takeda Pharmaceutical | |
| Size | $3-billion two-tranche 144A/RegS offering. Comprising $1.5 billion three-year and $1.5 billion five-year (Japan) |
| Joint bookrunners | Nomura, Morgan Stanley, BAML, Citi |
| Deal write-up | |
| Republic of the Philippines | |
| Size | $1.5 billion and Ps30.8 billion new global peso notes |
| Joint global coordinators | Credit Suisse, Deutsche Bank, HSBC |
| Joint bookrunners | Citi, Deutsche Bank, Goldman Sachs, HSBC, JPMorgan, Morgan Stanley, Standard Chartered, UBS |
| Deal write-up | |
| PICC Group | |
| Size | $3.56 billion H-share IPO (Hong Kong) |
| Joint global coordinators | Deutsche Bank, Goldman Sachs, Credit Suisse, CICC and HSBC |
| Deal write-up | |
| IHH Healthcare | |
| Size | $2.1 billion IPO (Malaysia) |
| Joint coordinators | BAML, CIMB, Deutsche Bank |
| Bookrunners | Credit Suisse, DBS Bank, Goldman Sachs |
| Deal write-up | |